$MEDS News

DataMEDS AI Launches 'Health Lives Here' Community Respiratory Program To Be Marketed To 6,500+ Independent Pharmacies In Its Corexa Health Pharmacy Network

DataMeds AI Enters IP License Agreement With Reboot Health AI On Oct 13, 2026; Reboot Grants DataMeds AI Exclusive License To Patents And Health AI Platform In U.S.; Reboot To Receive Portion Of DataMeds AI's Adj Gross Revenue; Co To Issue Reboot 666,667 Shares As IP License Stock Component

DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal

DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform

DataMeds AI To Collaborate With REBOOT Health AI To Integrate Its GLP Management Platform Into Its Health Lives Here Mobile App Under License Agreement

DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division

DataMeds AI Announces Workforce Reductions as It Prioritises ChemoFx Cancer Diagnostic Test Commercialisation

DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test

Datameds AI Subsidiary Helomics Receives Medicaid Coverage Determination In Gynecologic Cancers For The ChemoFx Assay In Gynecologic Cancers

DataMeds AI Corexa Pharmacy Surpasses $1 Million in Monthly Revenue as Sales Rise 66%

DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue

12 Health Care Stocks Moving In Thursday's Pre-Market Session

DataMeds AI Launches Health Lives Here App Focused on GLP-1 Telehealth and Pharmacy Services

DataMeds AI stock rises on health app launch

DataMeds AI Stock Surges on Mobile App Launch

DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit

DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked

DataMeds AI Settles Litigation Related To Outstanding Debt And Receivables Related To The 2023 Wellgistics Agreement; Company Retired ~364,099 MEDS Shares And Paid $450K In Cash

DataMEDS AI Enters Settlement Agreement On Sept 11, 2026; Expects To Extinguish $19M In Liability From Agreement

DataMEDS AI Q2 EPS $(7.13) Down From $(5.40) YoY, Sales $1.780M Down From $7.791M YoY